Laurine Noblecourt (Postdoc)

Laurine received her master’s degree from the Ecole Normale Supérieure of Lyon in 2018 during which she worked on developing CAR T cells at the Fred Hutchinson Cancer research in Seattle. She then completed her DPhil in the University of Oxford in 2023 where her work involved optimising combination therapies with cancer vaccines. She is pursuing her work on immunotherapy, engineering anti-tumour T cells with a focus on comprehending the complex balance between T cell fitness and effector functions. 

Contact: l.noblecourt@imperial.ac.uk